Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21245849rdf:typepubmed:Citationlld:pubmed
pubmed-article:21245849lifeskim:mentionsumls-concept:C1412056lld:lifeskim
pubmed-article:21245849lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:21245849lifeskim:mentionsumls-concept:C1705338lld:lifeskim
pubmed-article:21245849lifeskim:mentionsumls-concept:C1136102lld:lifeskim
pubmed-article:21245849lifeskim:mentionsumls-concept:C0231441lld:lifeskim
pubmed-article:21245849lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:21245849lifeskim:mentionsumls-concept:C0678812lld:lifeskim
pubmed-article:21245849lifeskim:mentionsumls-concept:C1366464lld:lifeskim
pubmed-article:21245849lifeskim:mentionsumls-concept:C0679058lld:lifeskim
pubmed-article:21245849lifeskim:mentionsumls-concept:C0449943lld:lifeskim
pubmed-article:21245849lifeskim:mentionsumls-concept:C0086022lld:lifeskim
pubmed-article:21245849lifeskim:mentionsumls-concept:C1547699lld:lifeskim
pubmed-article:21245849lifeskim:mentionsumls-concept:C2700640lld:lifeskim
pubmed-article:21245849lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:21245849lifeskim:mentionsumls-concept:C1705099lld:lifeskim
pubmed-article:21245849lifeskim:mentionsumls-concept:C0442335lld:lifeskim
pubmed-article:21245849pubmed:issue5lld:pubmed
pubmed-article:21245849pubmed:dateCreated2011-5-2lld:pubmed
pubmed-article:21245849pubmed:abstractTextAdeno-associated virus vectors (AAV) show promise for liver-targeted gene therapy. In this study, we examined the long-term consequences of a single intravenous administration of a self-complementary AAV vector (scAAV2/ 8-LP1-hFIXco) encoding a codon optimized human factor IX (hFIX) gene in 24 nonhuman primates (NHPs). A dose-response relationship between vector titer and transgene expression was observed. Peak hFIX expression following the highest dose of vector (2 × 10(12) pcr-vector genomes (vg)/kg) was 21 ± 3 µg/ml (~420% of normal). Fluorescent in-situ hybridization demonstrated scAAV provirus in almost 100% of hepatocytes at that dose. No perturbations of clinical or laboratory parameters were noted and vector genomes were cleared from bodily fluids by 10 days. Macaques transduced with 2 × 10(11) pcr-vg/kg were followed for the longest period (~5 years), during which time expression of hFIX remained >10% of normal level, despite a gradual decline in transgene copy number and the proportion of transduced hepatocytes. All macaques developed serotype-specific antibodies but no capsid-specific cytotoxic T lymphocytes were detected. The liver was preferentially transduced with 300-fold more proviral copies than extrahepatic tissues. Long-term biochemical, ultrasound imaging, and histologic follow-up of this large cohort of NHP revealed no toxicity. These data support further evaluation of this vector in hemophilia B patients.lld:pubmed
pubmed-article:21245849pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21245849pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21245849pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21245849pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21245849pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21245849pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21245849pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21245849pubmed:languageenglld:pubmed
pubmed-article:21245849pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21245849pubmed:citationSubsetIMlld:pubmed
pubmed-article:21245849pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21245849pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21245849pubmed:statusMEDLINElld:pubmed
pubmed-article:21245849pubmed:monthMaylld:pubmed
pubmed-article:21245849pubmed:issn1525-0024lld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:BronsonRoderi...lld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:DonahueRobert...lld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:ColemanJohnJlld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:WaddingtonSim...lld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:NathwaniAmit...lld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:NienhuisArthu...lld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:GrayJohn TJTlld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:HighKatherine...lld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:DavidoffAndre...lld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:NgCatherine...lld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:ZhouJunfangJlld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:RosalesCecili...lld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:McCarvilleM...lld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:MingozziFeder...lld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:JacksonScottSlld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:McIntoshJenny...lld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:SpenceYunyuYlld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:SleepSusanSlld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:RajDeepakDlld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:ValentineMarc...lld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:RastegarlariG...lld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:NathwaniDevhr...lld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:NawatheSushmi...lld:pubmed
pubmed-article:21245849pubmed:authorpubmed-author:AllayJamesJlld:pubmed
pubmed-article:21245849pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21245849pubmed:volume19lld:pubmed
pubmed-article:21245849pubmed:ownerNLMlld:pubmed
pubmed-article:21245849pubmed:authorsCompleteYlld:pubmed
pubmed-article:21245849pubmed:pagination876-85lld:pubmed
pubmed-article:21245849pubmed:meshHeadingpubmed-meshheading:21245849...lld:pubmed
pubmed-article:21245849pubmed:meshHeadingpubmed-meshheading:21245849...lld:pubmed
pubmed-article:21245849pubmed:meshHeadingpubmed-meshheading:21245849...lld:pubmed
pubmed-article:21245849pubmed:meshHeadingpubmed-meshheading:21245849...lld:pubmed
pubmed-article:21245849pubmed:meshHeadingpubmed-meshheading:21245849...lld:pubmed
pubmed-article:21245849pubmed:meshHeadingpubmed-meshheading:21245849...lld:pubmed
pubmed-article:21245849pubmed:meshHeadingpubmed-meshheading:21245849...lld:pubmed
pubmed-article:21245849pubmed:meshHeadingpubmed-meshheading:21245849...lld:pubmed
pubmed-article:21245849pubmed:meshHeadingpubmed-meshheading:21245849...lld:pubmed
pubmed-article:21245849pubmed:meshHeadingpubmed-meshheading:21245849...lld:pubmed
pubmed-article:21245849pubmed:meshHeadingpubmed-meshheading:21245849...lld:pubmed
pubmed-article:21245849pubmed:meshHeadingpubmed-meshheading:21245849...lld:pubmed
pubmed-article:21245849pubmed:meshHeadingpubmed-meshheading:21245849...lld:pubmed
pubmed-article:21245849pubmed:meshHeadingpubmed-meshheading:21245849...lld:pubmed
pubmed-article:21245849pubmed:year2011lld:pubmed
pubmed-article:21245849pubmed:articleTitleLong-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins.lld:pubmed
pubmed-article:21245849pubmed:affiliationDepartment of Hematology, University College London Cancer Institute, London, UK. a.nathwani@ucl.ac.uklld:pubmed
pubmed-article:21245849pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21245849pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:21245849pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:21245849lld:pubmed